Company attributes
Other attributes
Servier is an international pharmaceutical group of companies managed by a non-profit foundation. The company operates in 150 countries and employs 21,800 people worldwide. As a fully independent entity, the Servier Group reinvests more than 20% of its originator drug revenue in research and development. To accelerate innovation for the benefit of patients, the Group is committed to open and fruitful collaborations with academic partners, pharmaceutical groups and biotechnology companies. Patient opinion is at the core of Servier's activities, from scientific research to patient support programs.
As a leader in cardiology, the Servier Group aims to become a key player in the field of oncology. The company's high growth rates are due to continuous development in five key areas: cardiovascular diseases and metabolic disorders, oncology, neuropsychiatry and immunoinflammatory diseases; and activities to create high-quality generic drugs for the treatment of a wide range of diseases.
